Abstract

Piroxicam is a potent anti-inflammatory and antipyretic drug, which also has a protective action against different oxidative agents. Nevertheless, it also induces adverse side effects and it is considered as new emerging contaminant. An advanced oxidation process, Fenton chemistry, was chosen as a possible alternative for the degradation of Piroxicam in aqueous solution. Although Piroxicam is capable of complexing iron(II) and iron(III) metallic ions, it was found that the complexation does not prevent the development of Fenton’s reaction. The fundamental parameters of the Fenton process were determined by UV–vis spectrophotometry. Initial concentrations of iron(II) and hydrogen peroxide for the optimal degradation of the substrate at pH 3.0 are 3.69⋅10−4 mol L-1 and 0.53 mol L-1, respectively.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.